What Happened
An Anchorage jury convicted advanced nurse practitioner Kris Rhodes Kile in May 2025 of 12 felony counts of misconduct involving a controlled substance after evidence showed she prescribed fentanyl, oxycodone, hydrocodone, hydromorphone, and diazepam to six patients between June 2016 and November 2018 with no legitimate medical purpose. On November 14, 2025, an Anchorage Superior Court judge sentenced Kile to three years to serve, finding her prospects for rehabilitation "guarded" and her attitude "steadfastly unrepentant."
After a multi-week trial, an Anchorage jury found Kris Rhodes Kile guilty in May 2025 of 10 counts of felony second-degree misconduct involving a controlled substance and 2 counts of felony third-degree misconduct involving a controlled substance. The evidence established that Kile, then a licensed advanced nurse practitioner permitted to treat patients by prescription, prescribed fentanyl, oxycodone, hydrocodone, hydromorphone, and diazepam to six different patients between June 2016 and November 2018 without any medical purpose. On November 14, 2025, Anchorage Superior Court Judge Catherine Easter sentenced Kile to five years with two years suspended — three years to serve — followed by four years of probation, commenting that Kile 'is steadfastly unrepentant' and, if she still held a nursing license, 'would go out and do the same thing again.'
What Went Wrong
- A single advanced practice prescriber was able to write medically unjustified controlled-substance prescriptions for six separate patients over more than two years before facing charges.
- The multi-year gap between the prescribing conduct (2016–2018) and conviction (2025) illustrates how long prescription-drug misconduct cases can take to surface and prosecute compared to inventory-based diversion.
- The case shows prescribing-based diversion — writing scripts rather than stealing from stock — evades detection methods built around inventory reconciliation.
How It Could Have Been Prevented
- Cross-reference individual prescriber PMP output against patient panels and diagnosis codes to flag prescribing volumes or patterns inconsistent with documented medical need.
- Require periodic peer or supervisory chart review for advanced practice prescribers with independent prescribing authority, particularly for high-risk schedule II combinations.
- Encourage pharmacist and colleague reporting channels for prescribing patterns that raise red flags, since this case's oversight relied on prosecution rather than earlier licensure intervention.